Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares
14 déc. 2018 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its...
Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock
12 déc. 2018 01h01 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an...
Fluidigm Announces Commencement of Public Offering of Common Stock
11 déc. 2018 16h01 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to...
Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018
08 nov. 2018 08h30 HE
|
Fluidigm Corporation
A comprehensive suite of innovative immuno-oncology applications to improve the future of cancer care SOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation...
Fluidigm Recognized as a Company to Watch in 2019
07 nov. 2018 16h11 HE
|
Fluidigm Corporation
Immuno-oncology innovator receives life science people’s choice award SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm...
Fluidigm Announces Third Quarter 2018 Financial Results
01 nov. 2018 16h05 HE
|
Fluidigm Corporation
Total revenue increases 17 percent to $29.0 million Mass cytometry revenue growth of 50 percent Instrument revenue growth of 32 percent SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018...
Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development
01 nov. 2018 08h30 HE
|
Fluidigm Corporation
Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sirona Dx,...
Fluidigm Announces Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis
10 sept. 2018 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Visiopharm A/S today announced a co-marketing relationship to automate image analysis for...
Fluidigm to Host 2nd Annual Imaging Mass Cytometry User Group Meeting
09 août 2018 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced it will hold its 2nd Annual Imaging...
Fluidigm to Participate in Upcoming Investor Events
09 mai 2018 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...